Emergency Department Interventions Cut Opioid Rx Rates
THURSDAY, Jan. 20, 2022 (HealthDay News) -- Most emergency department interventions aimed at cutting opioid prescribing cut the prescription rate but not the prescribed opioid quantity, according to a review published online Jan. 13 in JAMA Network Open.
Raoul Daoust, M.D., from Le Centre Intégré Universitaire de Santé et de Services Sociaux du Nord-de-l’Île de-Montréal, and colleagues conducted a systematic literature review to identify intervention studies aimed at reducing opioid prescriptions at emergency department discharge.
Based on 45 studies included in the meta-analysis, the researchers found a statistically significant reduction in the opioid prescription rate for both interrupted time series (ITS; six-month step change, −22.61 percent) and other study designs (odds ratio, 0.56). ITS studies showed no significant reduction in prescribed opioid quantities (six-month step change, −8.64 percent), but there was a small, significant reduction in other study designs (standardized mean difference, −0.30). Education, policies, and guideline interventions were better at reducing the opioid prescription rate in ITS studies (six-month step change, −33.31 percent) versus prescription drug monitoring programs and laws (six-month step change, −11.18 percent). Prescribed opioid quantities were not reduced by most intervention categories.
"Novel interventions are needed to reduce the quantity of opioids per prescription by emergency department physicians while evaluating their associations with patient-centered outcomes," the authors write.
Related Posts
2012 to 2015 Saw Rise in U.S. Insulin Prices
FRIDAY, June 16, 2023 (HealthDay News) -- U.S. insulin prices substantially...
AHA News: Neurologist Wakes Up in the Hospital Where She Works – As a Stroke Survivor
WEDNESDAY, Sept. 8, 2021 (American Heart Association News) -- Dr. Dipika...
Los órganos donados por las personas que tuvieron COVID son seguros, según un estudio
MIÉRCOLES, 23 de marzo de 2022 (HealthDay News) -- Una nueva investigación...
FDA Panel Backs RSV Vaccine for Infants, Some Toddlers
FRIDAY, June 9, 2023 (HealthDay News) -- A U.S. Food and Drug Administration...